Insmed Incorporated
INSM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$370,021 | -$321,686 | -$256,583 | -$235,548 |
| Dep. & Amort. | $3,996 | $3,747 | $3,146 | $2,741 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $31,433 | $42,976 | $39,262 | $26,554 |
| Change in WC | $13,896 | $9,538 | -$66,090 | $28,122 |
| Other Non-Cash | $100,935 | $59,856 | $18,177 | -$17,848 |
| Operating Cash Flow | -$219,761 | -$205,569 | -$262,088 | -$195,979 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,418 | -$3,484 | -$10,070 | -$6,772 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$1,184,815 | -$276,681 | -$630,518 | -$577,470 |
| Inv. Sales/Matur. | $425,000 | $508,000 | $721,000 | $716,000 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$762,233 | $227,835 | $80,412 | $131,758 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$747 | -$2,697 | -$706 | $145,577 |
| Stock Issued | $34,157 | $860,503 | $29,704 | $13,728 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $33,410 | $857,806 | $28,998 | $159,305 |
| Forex Effect | -$976 | $1,005 | $895 | -$1,505 |
| Net Chg. in Cash | -$949,560 | $881,077 | -$151,783 | $93,579 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,284,324 | $403,247 | $555,030 | $461,451 |
| End Cash | $334,764 | $1,284,324 | $403,247 | $555,030 |
| Free Cash Flow | -$222,179 | -$209,053 | -$272,158 | -$202,751 |